18 March 2021>: Clinical Research
Atosiban Combined with Ritodrine for Late Threatened Abortion or Threatened Premature Labor Patients with No Response to Ritodrine: A Clinical Trial
Shuai Fu 1ABC* , Haitian Xie 1DEF* , Yilei Zhong 12BCD* , Qi Xu 1D , Liqiong Zhu 1B , Hanjie Mo 1B , Jianping Zhang 1AG , Yinglin Liu 1CF , Hui Chen 1AG , Yonghong Zhong 2AD* , Jianping Tan 1AD*DOI: 10.12659/MSM.929743
Med Sci Monit 2021; 27:e929743
Table 5 Adverse drug reactions. Categorical data are shown as a frequency (percentage) and continuous data are shown as mean±SD. The t test was used for analyzing quantitative data, and the χ2 test was used for analyzing categorical data. P<0.05 was considered statistically significant.
Items | Control group (n=22) | Research group (n=30) | P |
---|---|---|---|
Mean heart rate (times/min) | 98.77±9.06 | 97.46±15.84 | 0.703 |
Palpitations (%) | 68.20 (15/22) | 13.30 (4/30) | * |
Chest pain (%) | 0.00 (0/22) | 6.67 (2/30) | 0.520 |
* |